LeMaitre Vascular Stock Is a Beaten-Down Medical Devices Play for 2019
In my search for small-cap contrarian ideas that could rally in 2019, I'm intrigued by the opportunity in LeMaitre Vascular Inc (NASDAQ:LMAT), a developer of innovative devices and solutions geared to battle vascular diseases.
Given that LMAT stock is down 36% over the past three months and 45% from its April 2018 high, I see an aggressive opportunity after the move to the 52-week low of $21.79 on December 24.
With a market cap at around $445.0 million, LMAT stock is small and is delivering revenue growth along with positive earnings before interest, taxes, depreciation, and.
Den vollständigen Artikel lesen ...
In my search for small-cap contrarian ideas that could rally in 2019, I'm intrigued by the opportunity in LeMaitre Vascular Inc (NASDAQ:LMAT), a developer of innovative devices and solutions geared to battle vascular diseases.
Given that LMAT stock is down 36% over the past three months and 45% from its April 2018 high, I see an aggressive opportunity after the move to the 52-week low of $21.79 on December 24.
With a market cap at around $445.0 million, LMAT stock is small and is delivering revenue growth along with positive earnings before interest, taxes, depreciation, and.
Den vollständigen Artikel lesen ...